Fresenius SE & Co. (OTCMKTS:FSNUY) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Fresenius SE & Co. (OTCMKTS:FSNUY) released its quarterly earnings results on Wednesday. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01), Zacks reports. Fresenius SE & Co. had a return on equity of 10.09% and a net margin of 6.55%.The firm had revenue of $6.91 billion for the quarter, compared to analyst estimates of $6.69 billion.

Fresenius SE & Co. Stock Performance

Fresenius SE & Co. stock opened at $13.56 on Thursday. Fresenius SE & Co. has a 52-week low of $10.33 and a 52-week high of $33.93. The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $30.55 billion, a price-to-earnings ratio of 18.08 and a beta of 0.61. The firm has a 50-day moving average price of $11.75 and a two-hundred day moving average price of $12.77.

Analysts Set New Price Targets

Separately, Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a research note on Tuesday, July 21st. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy”.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.